Document Detail

Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes.
MedLine Citation:
PMID:  20645073     Owner:  NLM     Status:  MEDLINE    
J A Johnson; M Pollak
Related Documents :
22593683 - Effect of potent ethyl acetate fraction of stereospermum suaveolens extract in streptoz...
1511573 - Clinical and metabolic characteristics of type 1 and type 2 diabetes: an epidemiologica...
24666993 - Ruscogenin ameliorates diabetic nephropathy by its anti-inflammatory and anti-fibrotic ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-07-20
Journal Detail:
Title:  Diabetologia     Volume:  53     ISSN:  1432-0428     ISO Abbreviation:  Diabetologia     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-02     Completed Date:  2011-01-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0006777     Medline TA:  Diabetologia     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  2086-8     Citation Subset:  IM    
School of Public Health, University of Alberta, 2-040 Li Ka Shing Center for Health Research Innovation, Edmonton, AB T6G 2E1, Canada,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Glucose*
Diabetes Mellitus, Type 2 / drug therapy*
Hypoglycemic Agents / adverse effects
Insulin / adverse effects*
Neoplasms / etiology*
Grant Support
MOP-82737//Canadian Institutes of Health Research; OTG-88588//Canadian Institutes of Health Research
Reg. No./Substance:
0/Blood Glucose; 0/Hypoglycemic Agents; 11061-68-0/Insulin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Human hepatocyte transplantation.
Next Document:  Contribution of postnatally formed small beta cell aggregates to functional beta cell mass in adult ...